Total: 1
N6-methyladenosine (m6A) is the most abundant internal modification in eukaryotic mRNA. However, most existing predictors use adenosine-centered formulations that are computationally inefficient and prone to false positives. Here we present m6A-FORM, a transformer-based foundation model for RNA methylation that uses MeRIP-seq peaks as methylation-enriched priors and is pretrained on approximately 22 million peak-derived sequences from 143 human MeRIP-seq studies. After fine-tuning with high-confidence single-nucleotide m6A annotations from m6A-Atlas v2.0 and GLORI, m6A-FORM-sites achieves state-of-the-art m6A site prediction performance, with a PR-AUC of 0.635 and ROC-AUC of 0.988, improving PR-AUC by at least 0.14 over existing methods while enabling substantially faster inference. Task-specific adaptation further supports prediction of binding sites for 19 m6A-associated regulators and identification of YTHDF2-bound m6A sites associated with mRNA degradation. Applying m6A-FORM across 67 datasets from 24 human tissues identifies 19,631 tissue-conserved sites with distinct localization, clustering, methylation, expression, RBP-interaction, and decay-associated signatures.